Synopsis
This presentation will review the decision process to arrive at an
optimal combination of MR sequence elements, such as spatial localization,
water suppression and spectral editing. Examples of specific applications,
metabolites and MR hardware limitations will be provided to demonstrate that an
optimal choice for one condition may not necessarily be optimal for a different
one. While guidelines and decision trees can help the user under most
experimental conditions, an intimate knowledge of each specific MR method is
required when straying off the beaten path.
Introduction
This year celebrates the 45th anniversary of the first in vivo MR spectroscopy (MRS) study
performed by Hoult and coworkers (1). Since that time in vivo MRS has seen a dramatic development from one-pulse methods
to extended pulse sequences employing multiple RF pulses, magnetic field gradients
and delays. Today there are dozens of MR methods with colorful acronyms for
spatial localization, water and/or lipid suppression and spectral editing (2). For a MR novice the range of available
techniques can be overwhelming and the right choice and combination of methods may
not always be obvious, especially since each technique has its own specific
limitations that may or may not be important for the application at hand. Here
we will discuss several decision trees that can be followed to arrive at an
optimal MR pulse sequence combination for a given application, experimental
setup and magnetic field strength.The challenge
Fig. 1 graphically depicts the challenge that a MR
spectroscopist faces when selecting an optimal combination of MR methods for a
particular application and/or metabolite. The key to successfully selecting a
suitable MR method is to understand the limitations of each method together
with the additional limitations posed by the available MR parameters. Fortunately,
as NMR in general and in vivo MRS in
particular is one of the most flexible techniques ever developed, there is
typically more than one combination that can provide satisfactory results.Possible solutions
Table 1 shows a summary of several important features of available
spatial localization methods. A cursory glance reveals that no single method
excels at all features, so that a decision must be based on a relative balance
between the various features. For example, LASER localization (3) provides excellent spatial localization,
minimal chemical shift displacements and high SNR. However, LASER is rarely
used in high-field human brain applications due to RF power deposition concerns
and the long minimum echo-time TE. In animal studies, LASER is the preferred
localization method, since short RF pulses can be employed due to the higher
maximum RF amplitude, thereby giving a minimum TE of circa 10 ms. Instead
of being guided purely by technical MR considerations, the decision can also be
based on application-related factors (Fig. 2). When faced with a pathology that
homogeneously affects specific parts of the brain (e.g. frontal cortex in many
psychiatric disorders), spatial localization of a single volume may be
sufficient and has the advantage of a well-defined volume definition. In the
case of pathologies that affect the brain heterogeneously (e.g. cancer,
multiple sclerosis) it may be better to perform MR spectroscopic imaging (MRSI)
to obtain an unbiased view. Decisions further down the tree may be based on additional
application-specific concerns or may be guided by MR hardware limitations. Once
an optimal spatial localization method has been selected, additional decision
trees can be set up for water and/or lipid suppression and selective metabolite
detection through spectral editing.Conclusions
This presentation will review the decision process to arrive at an
optimal combination of MR sequence elements, such as spatial localization,
water suppression and spectral editing. Examples of specific applications,
metabolites and MR hardware limitations will be provided to demonstrate that an
optimal choice for one condition may not necessarily be optimal for a different
one. While guidelines and decision trees can help the user under most
experimental conditions, an intimate knowledge of each specific MR method is
required when straying off the beaten path.Acknowledgements
No acknowledgement found.References
1. Hoult DI, Busby SJ, Gadian DG, Radda
GK, Richards RE, Seeley PJ. Observation of tissue metabolites using 31P
nuclear magnetic resonance. Nature 1974;252:285-287.
2. de
Graaf RA. In Vivo NMR Spectroscopy.
Principles and Techniques. Chichester: John Wiley; 2019.
3. Garwood
M, DelaBarre L. The return of the frequency sweep: designing adiabatic pulses
for contemporary NMR. J Magn Reson 2001;153:155-177.